A pulsed discharge produced underwater has been an attractive method to treat waste water. For the optimization and realization of the water treatment system utilizing underwater pulsed discharge, modeling analysis could be one of the essential works. However, there is still no simulation work about the underwater pulsed discharge due to the lack of knowledge about its characteristic parameters such as electron temperature, electron density, and so on. In this paper, the temperature and the electron density in a pulsed discharge plasma produced underwater are measured and presented. A magnetic pulse compressor (MPC) was developed and used to create the electrical discharge in water. The developed MPC is all-solid state and is, therefore, a maintenance-free generator. To define the temperature and the electron density in an underwater pulsed discharge plasma, two kinds of spectroscopic measurements, called the line-pair method and Stark broadening, were carried out. According to the experimental results, the temperature and the electron density in the pulsed discharge plasma between point-plane electrodes immersed in water are determined to be 15 000 K and 10 18 /cm 3 , respectively.
PADI4 is an autoantigen in some RA patients, and its conformational epitope(s) may be important.
In a 71-year-old woman with primary squamous cell carcinoma of the thyroid, marked leukocytosis (26,000 to 87,000/mm3), in which about 90% were mature neutrophils, was observed. Hypercalcemia (about 12 mg/100 ml) was also observed with the serum inorganic phosphate within normal limits. The serum parathyroid hormone (PTH) was undetectable. The thyroid tumor was successfully transplanted to athymic nude mice at autopsy. Marked leukocytosis and hypercalcemia was reproduced in the tumor-bearing nude mice. The result indicates that the thyroid cancer was secreting humoral factors(s) producing leukocytosis and hypercalcemia. The association of leukocytosis and hypercalcemia has been reported in the two similar cases of squamous cell carcinoma, in which the tumor was proven to secrete colony-stimulating factor (CSF). Leukocytosis and hypercalcemia may thus form a new paraneoplastic syndrome.
In this study, we used magnetic resonance (MR) imaging to measure portal blood flow in 12 healthy controls and 17 cirrhotics while they were breath-holding after inspiration and after expiration. We then compared the results with measurements made during normal respiration in the healthy controls and cirrhotics. Blood flow in the main portal vein under basal fasting conditions was quantitated using the cine phase-contrast MR velocity mapping method. Three measurements were made on one occasion, as follows: (1) throughout the cardiac cycle during normal respiration, (2) with the subject breath-holding after maximal inspiration, and (3) with the subject breath-holding after maximal expiration. During normal respiration, portal blood flow was 1.3 +/- 0.21/min in controls vs 1.0 +/- 0.11/min in cirrhotics (P < 0.0001); while subjects were breath-holding after inspiration, portal blood flow was 1.0 +/- 0.21/min in controls vs 0.9 +/- 0.11/min in cirrhotics; and while subjects were breath-holding after expiration, portal blood flow was 1.5 +/- 0.21/min in controls vs 1.1 +/- 0.21/min in cirrhotics (P < 0.0001). The differences were primarily due to changes in flow velocity. When the magnitude of these hemodynamic changes in the three respiratory conditions was compared in controls and cirrhotics, analysis of variance (ANOVA) showed a significant difference (P < 0.0001). In controls, portal blood flow decreased during maximal inspiration relative to flow during normal respiration (-24.6 +/- 8.3%). Changes in portal blood flow in controls were greater than in cirrhotics (-13.5 +/- 4.5%) (P < 0.0001); however, the difference in blood flow increase associated with maximal expiration between the two groups (+11.8 +/- 9.4% vs +5.9 +/- 11.5%) was not significant. We found that the respiration-induced hemodynamic variation in portal blood flow was less in cirrhotics than in the healthy controls. Portal blood flow measurements made during normal respiration using MR imaging closely reflect nearly physiologic conditions.
In 14 patients with overt primary hypothyroidism, we examined visual fields by Goldmann's isopter perimetry. An unexpectedly high incidence (10 patients, 71.4%) of visual field defects was found. Two patients complained of visual failure, whereas 12 had no subjective symptoms. The extent of visual field change varied over a wide range, from early chiasmal compression to apparent bitemporal hemianopsia. The abnormality was characteristically restriction in the central visual field; peripheral vision was less often affected. The sella turcica was significantly enlarged in these patients as compared to controls. The volume of the sella turcica correlated significantly with both basal serum TSH and total pituitary reserve of TSH (r = 0.82, P less than 0.001). There was no correlation between the extent of visual field change and the volume of the sella turcica or pituitary TSH reserve. Of 10 patients with visual field defects, 8 improved during 1-4 months of T4 replacement. In 2 patients, however, the visual field defect deteriorated during replacement. The deterioration occurred when serum TSH levels had decreased to about 50% and 20% of pretreatment values, respectively. The peak serum TSH after TRH stimulation was higher at the time of deterioration than before treatment. Visual fields became normal during treatment with an increased dose of T4 (200 micrograms/day), when serum TSH was suppressed to an undetectable level. The paradoxical course of visual failure during T4 replacement may be due to an imbalance between TSH synthesis in the pituitary and TSH release which may induce an increase in pituitary size. The data suggest that visual field defects and their deterioration are due to pituitary hyperplasia and are reversible with T4 replacement. In order to rule out a pituitary tumor, hypothyroid patients with visual failure should be followed during T4 replacement therapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.